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Mdm2-Mediated NEDD8 Conjugation of p53
Inhibits Its Transcriptional Activity
single polypeptide, the NEDD8 E1 enzyme is a hetero-
dimer composed of the amyloid precursor protein bind-
ing protein (APP-BP1) and Uba3 protein. The E2 conju-
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the importance of the NEDD8 conjugation pathway inDundee DD1 9SY
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dopsis, mutations in the AXR1 gene (the homolog ofSchool of Biology
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which regulates cell division, cell elongation, and cellScotland
differentiation. In Saccharomyces cerevisiae and in fis-United Kingdom
sion yeast, the NEDD8 modifying pathway is essential
for cell growth and viability, respectively (Lammer et al.,
1998; Osaka at al., 2000). In addition, a temperature-Summary
sensitive mutation in the SMC gene, the hamster homo-
log of human APP-BP1, is responsible for the dramaticThe only reported role for the conjugation of the
cell cycle defects observed in TS-41 hamster cells. AtNEDD8 ubiquitin-like molecule is control of the activity
the restrictive temperature, these cells undergo multipleof SCF ubiquitin ligase complexes. Here, we show that
rounds of DNA replication without intervening mitosesthe Mdm2 RING finger E3 ubiquitin ligase can also
(Handeli and Weintraub, 1992). Further evidence for thepromote NEDD8 modification of the p53 tumor sup-
importance of the NEDD8 pathway for proliferation inpressor protein. Mdm2 is itself modified with NEDD8
mammals came from studies in mice (Tateishi et al.,with very similar characteristics to the autoubiquitina-
2001). Deletion of the Uba3 gene, encoding for the cata-tion activity of Mdm2. By using a cell line (TS-41) with
lytic component of the NEDD8-activating heterodimera temperature-sensitive mutation in the NEDD8 con-
enzyme, caused embryonic death. At the molecularjugation pathway and a p53 mutant that cannot be
level, the only well-characterized substrate so far forNEDDylated (3NKR), we demonstrate that Mdm2-
NEDD8 conjugation (NEDDylation) is members of thedependent NEDD8 modification of p53 inhibits its tran-
cullin family of proteins (Lammer et al., 1998; Liako-scriptional activity. These findings expand the role for
poulos et al., 1998; Osaka et al., 1998), although recentMdm2 as an E3 ligase, providing evidence that Mdm2
studies suggest that the cytoskeleton could be anotheris a common component of the ubiquitin and NEDD8
target for this pathway (Kurz et al., 2002). Cullins are aconjugation pathway and indicating the diverse mech-
common subunit of Roc1/Rbx1/Hrt1-Skp1-cullin/Cdc53-Fanisms by which E3 ligases can control the function
box (SCF) complexes, which regulate the stability ofof substrate proteins.
various proteins involved in cell cycle control and signal
transduction, including p27Kip1, IB, and HIF1-. (De-Introduction
shaies, 1999; Karin and Ben-Neriah, 2000; Kondo and
Kaelin, 2001; Ohh et al., 2002; Bloom and Pagano, 2003).
Ubiquitin is the founder member of the family of ubiqui-
Mechanistically, NEDDylation of cullins appears to regu-
tin-like proteins. These are small proteins that are cova-
late the E3 ubiquitin ligase activity of the SCF complex.
lently ligated to other proteins via an isopeptide linkage Recent studies showed that NEDD8 modification facili-
between the C-terminal carboxyl group of ubiquitin-like tates the recruitment of the E2 ubiquitin-conjugating
proteins and the -amino group of a lysine residue in enzyme to the SCF complex and/or mediate dissociation
the modified protein (Ciechanover, 1998). In addition to of p120Cand1, an inhibitor of cullins and SCF ligase activity
ubiquitin, the family of ubiquitin-like proteins includes (Kawakami et al., 2001; Liu et al., 2002; Wu et al., 2002).
ubiquitin crossreactive protein (UCRP or ISG15), SUMO-1 The ability of the Roc1/Rbx1/Hrt1 protein, a component
(also known as Smt3c, GMP1, or sentrin/Ubl1/Pic1), of the SCF complexes, to promote NEDDylation of cul-
NEDD8 (also known as Rub1), and Apg12. While ubiquiti- lins suggested that it could act as an E3 NEDD8 ligase
nation can target proteins for proteasomal degradation, (Kamura et al., 1999; Gray et al., 2002; Morimoto et
conjugation of ubiquitin-like molecules has novel regula- al., 2003).
tory functions (Weissman, 2001). The p53 tumor suppressor protein is a short-lived
Among the ubiquitin-like protein family, NEDD8 is protein due to its rapid proteasomal degradation. Upon
most homologous to ubiquitin. NEDD8 conjugation is exposure of cells to various stress stimuli, levels of p53
mechanistically similar to ubiquitination, in that NEDD8 rise as a consequence of reduced proteolytic degrada-
is activated and transferred to substrates by E1 and E2 tion, and its function as a transcription factor is acti-
enzymes. Unlike the ubiquitin E1 enzyme, which is a vated. This results in induction of a program of gene
expression that promotes cell growth arrest and/or
apoptosis (Lain, 2003; Woods and Lane, 2003). An im-*Correspondence: d.p.lane@dundee.ac.uk
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portant regulator of the stability/activity of p53 is the tions, His6-NEDD8 conjugated species purified on Ni2-
agarose beads, and samples analyzed by Western blot-Mdm2 oncogene product. Mdm2 directly interacts with
p53, promoting its ubiquitination and degradation ting using the 4B2 anti-Mdm2 antibody. While wild-type
Mdm2 was conjugated to NEDD8, no conjugation wasthrough the 26S proteasome (Bottger et al., 1997; Kub-
butat et al., 1997; Haupt et al., 1997). The importance observed with any of the Mdm2 mutants used (Figure
1B, top panel). NEDD8 conjugation of Mdm2 appearedof this interaction was demonstrated when the lethality
of mdm2 null mice was rescued by simultaneous dele- to depend on the cysteine residue 462 in the RING finger
domain. Cysteine 462 (464 in human) has been pre-tion of the p53 gene (Jones et al., 1995; Luna et al.,
1995). Furthermore, mice with a hypomorphic allele of viously characterized as one of the cysteines that coor-
dinate zinc and is required for Mdm2 to promote its ownmdm2 exhibited increased p53 transcriptional activity
and apoptotic function (Mendrysa et al., 2003). These ubiquitination as well as the ubiquitination of p53 (Fang
et al., 2000; Honda and Yasuda, 2000).data show that a key activity of Mdm2 in homeostatic
tissues is to inhibit the growth-suppressing effects of
p53. Biochemical studies showed that Mdm2 can act Mdm2 Promotes NEDDylation of p53 In Vivo
as an E3 ubiquitin ligase, and this activity depends on The observation that Mdm2 could be conjugated to
its RING finger domain at the C terminus of the protein NEDD8 dependent on the Cys462, which is required for
(Honda et al., 1997; Honda and Yasuda, 2000; Fang et its ubiquitin ligase activity, prompted us to investigate
al., 2000; Midgley et al., 2000). Mdm2 can also regulate the possibility that Mdm2 may act as an E3 NEDD8
its own stability through an autoubiquitination activity, ligase. One of the best-characterized substrates for
targeting itself for proteasomal degradation. There is Mdm2-mediated ubiquitination is the p53 tumor sup-
now evidence that the “trans” and “auto” ubiquitin ligase pressor protein. To determine whether Mdm2 could pro-
activity of Mdm2 can be differentially regulated through mote conjugation of NEDD8 to p53, wild-type human
its interaction with other proteins. The p14ARF tumor p53 was expressed in H1299 cells along with the His6-
suppressor protein and the Mdm2 homolog Mdmx both NEDD8 expression construct in the absence or presence
interact with Mdm2 and can preferentially inhibit p53 of Mdm2. NEDDylated p53 was isolated on Ni2-NTA
ubiquitination or Mdm2 autoubiquitination, respectively agarose and detected by Western blotting. Whole cell
(Xirodimas et al., 2001a; Stad et al., 2001). Other Mdm2- lysates were analyzed directly by Western blotting for
interacting proteins can also regulate the Mdm2-medi- determination of total p53 levels. NEDDylated p53 was
ated degradation of p53, including TSG101, the retinoblas- detected in the absence of coexpressed Mdm2 (Figure
toma protein (pRb), the c-Abl protooncogene product, and 2A, lane 2); however, the amount of NEDDylated p53 was
p300 (Vousden, 2002; Michael and Oren, 2003). These dramatically increased by Mdm2 coexperession (Figure
data demonstrate that the E3 ubiquitin ligase activity of 2A, lane 4). Treatment of cells with the proteasome inhib-
Mdm2 and the degradation pathway for p53 and Mdm2 itor MG132 protected p53 protein from Mdm2-mediated
are very tightly controlled in cells. downregulation and resulted in accumulation of p53
In this report, we demonstrate that Mdm2 promotes conjugated to NEDD8 (Figure 2A, lane 5). To further
conjugation of NEDD8 to p53. Mdm2 is itself modified demonstrate that the immunoreactive p53 isolated by
with NEDD8, and this reaction displays very similar char- Ni2-NTA agarose is p53 conjugated to NEDD8, a re-
acteristics to the autoubiquitination activity of Mdm2. cently described cysteine protease (NEDP1), which spe-
The following experiments characterize this activity of cifically cleaves NEDD8 molecules from conjugated
Mdm2 and determine the biological significance of this substrates, was coexpressed (Mendoza et al., 2003).
modification as a mechanism of control of p53 and Whereas expression of p53 in the presence of His6-
Mdm2 function. NEDD8 and Mdm2 results in accumulation of modified
p53 species, these species were not detected in the
presence of NEDP1 (Figure 2B, lane 3). Expression ofResults
the NEDP1Cys, which is catalytically inactive, had no
effect on p53 modification (Figure 2B, lane 4). The SSP3Mdm2 Is Conjugated to NEDD8 In Vivo
The only reported role for NEDD8 conjugation is to regu- SUMO-specific cysteine isopeptidase, which can re-
verse the SUMO-1 modification of p53 (Figure 2B, lanelate the E3 ubiquitin ligase activity of SCF complexes
through conjugation to cullin family member proteins 9), had no effect on p53 modification with His6-NEDD8
(Figure 2B, lane 5). The NEDP1 protease had no effect(see Introduction). The Mdm2 protein is a well-charac-
terized RING finger type E3 ubiquitin ligase that directs on Mdm2-mediated ubiquitination of p53, demonstra-
ting the specificity of the protease for NEDD8 cleavageubiquitination of the p53 tumor suppressor protein but
also has a potent autoubiquitination activity. To deter- (Figure 2B, lane 13). The appearance of high molecular
weight p53 species in our His6-NEDD8 pull-downs sug-mine if Mdm2 is a potential substrate for NEDD8 con-
jugation, we used a well-established approach where gested that other posttranslational modifications such
as ubiquitin conjugation could simultaneously takeconjugation of different substrates to ubiquitin and ubi-
quitin-like molecules can be detected (Rodriguez et al., place. To address this possibility, we used the p53-
specific deubiquitinating enzyme HAUSP/USP7 (Everett1999; Xirodimas et al., 2001a).
H1299 cells (genetically negative for p53) were trans- et al., 1997; Li et al., 2002). As before, we transfected
H1299 cells with p53, Mdm2, His6-NEDD8 expressionfected with plasmids expressing either wild-type Mdm2
or Mdm2 mutants (Figure 1A) along with a vector ex- constructs, and, where indicated, increasing amounts
of HAUSP or its catalytic inactive mutant, HAUSPCys.pressing a Histidine-tagged (His6) version of human
NEDD8. Cells were lysed under strong denaturing condi- As shown in Figure 2C, HAUSP clearly rescued p53 from
Mdm2 Promotes NEDD8 Conjugation of p53
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Figure 1. Mdm2 Is Conjugated to NEDD8
In Vivo
(A) Schematic representation of wild-type
Mdm2 and Mdm2 mutants (Midgley et al.,
2000).
(B) H1299 cells were transfected as indicated
with 5 g of Mdm2 and 2 g of His6-NEDD8
expressing constructs. Posttransfection (36
hr), cells were lysed in guanidinium chloride,
and His6-NEDD8 conjugated species were
purified on Ni2-NTA agarose as described
in Experimental Procedures. NEDDylated
Mdm2 (top panel) and total Mdm2 (bottom
panel) were analyzed by Western blotting us-
ing the 4B2 monoclonal antibody.
Mdm2-mediated degradation (bottom panel). Under protein. To demonstrate that direct interaction of endog-
enous Hdm2 with p53 is required for p53 NEDDylation,these conditions, HAUSP prevented the formation of
high molecular weight p53 species but did not affect we performed the experiment in H1299 cells in the pres-
ence of super thioredoxin insert protein (STIP). This isthe more slowly migrating NEDD8 modified species,
suggesting that NEDDylated p53 is also modified with a high-affinity (H)Mdm2 binding peptide in the p53 bind-
ing pocket, fused to thioredoxin, which disrupts theubiquitin.
Despite the overexpression of p53 and His6-NEDD8, (H)Mdm2-p53 interaction (Bottger et al., 1997). Increas-
ing amounts of transfected STIP reduced the amountthe NEDD8 conjugation activity observed in Figure 2A,
lane 2, depends entirely on the endogenous NEDD8 of NEDDylated p53 detected (Figure 2E, lanes 3–5). Fur-
thermore, a single point p53 mutant (F19A), which isconjugation machinery and endogenous E3 ligase(s). To
determine whether this activity depends on the endoge- previously shown to be deficient for Mdm2 binding (Liu
et al., 2001; Xirodimas et al., 2001b), showed no NEDD8nous Hdm2, we performed the experiment described in
Figure 2A in H1299 cells which had been transfected modification under the same conditions. These data
strongly suggest that NEDDylation of p53 depends onwith either control or Hdm2 siRNA. As shown in Figure
2D, knockdown of endogenous Hdm2 resulted in de- the expression of Hdm2 and that this reaction also re-
quires interaction of p53 with endogenous Hdm2.crease of NEDDylated p53. A similar experiment was
performed in MCF7 cells that contain wild-type p53 and
have been established to express His6-NEDD8. Knock- NEDDylation of p53 In Vitro
To address the action of Mdm2 as an E3 NEDD8 ligasedown of Hdm2 resulted in upregulation of endogenous
p53 levels and decrease of NEDDylated p53 (Figure 2D, for p53, we established an in vitro assay for NEDDylation
of p53. Recombinant APP-BP1/Uba3 (E1), Ubc12 (E2),right panel). Therefore, the ratio of NEDDylated p53 over
total p53 protein is reduced upon knockdown of Hdm2 and NEDD8 were incubated with bacterially expressed
Cell
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p53 and Mdm2 in the presence of ATP, as described in and NEDD8 conjugation of p53 was specific for these
two molecules or could be extended to other ubiquitin-Experimental Procedures. After incubation at 37C for
2 hr, reactions were terminated and p53 species de- like molecules, p53 and Mdm2 were coexpressed with
His6 versions of ubiquitin and ubiquitin-like moleculestected by Western blotting using the well-characterized
DO-1 anti-p53 monoclonal antibody. Increasing amounts such as NEDD8, SUMO-1, and ISG15. His6-tagged puri-
fied species were analyzed for p53 by Western blottingof added Ubc12 resulted in appearance of more slowly
migrating p53 species whose molecular weights corre- as before. Mdm2 could clearly promote conjugation of
ubiquitin and NEDD8 to p53 (Figure 3G, top panel, lanesspond to the addition of one or two NEDD8 molecules
to p53. The appearance of these species was dependent 2 and 4) but had no effect on either SUMO-1 or ISG15
conjugation (Figure 3G, top panel, lanes 6 and 8). Thison the addition of E1, E2, and NEDD8 (Figure 3A). Quanti-
tation of the signals in each lane demonstrated a linear is not a consequence of differences in the expression
levels of the various ubiquitin-like proteins, as His6-increase in p53 modification upon addition of increasing
amounts of Ubc12 (Figure 3B). These data also show SUMO-1 and His6-ISG15 are both expressed to higher
levels than His6-Ubiquitin or His6-NEDD8 (data notthat modification of p53 with NEDD8 could occur in vitro
in the absence of an E3 ligase. Addition of recombinant shown). The decrease in SUMO-1 modification of p53
upon coexpression of Mdm2 is likely to be due to de-Mdm2 to reactions containing 100 ng of Ubc12 resulted
in a moderate increase in NEDD8 modification of p53 crease of p53 protein levels (Figure 3G, lower panel,
compare lanes 5 and 6).(Figure 3C), while the same Mdm2 sample very efficiently
promoted p53 ubiquitination. Quantitation of the modi-
fied species demonstrated that NEDD8 modification Mdm2-Mediated NEDDylation of p53 Requires
Lysines K370, K372, and K373 in the Cwas stimulated by addition of increasing amounts of
recombinant Mdm2 (Figure 3D). Terminus of p53
Previous studies on Mdm2-mediated ubiquitination of
p53 identified six lysines in the C terminus of p53 (K370,Endogenous p53 and Mdm2 Are Modified
with Endogenous NEDD8 K372, K373, K381, K382, and K386), which are required
for efficient Mdm2-mediated ubiquitination and protea-To determine whether p53 and Mdm2 are subject to
NEDD8 modification at endogenous expression levels, somal degradation of p53 (Nakamura et al., 2000; Rodri-
guez et al., 2000). To determine the lysines requiredwe performed immunoprecipitations using extracts from
different cell lines with anti-p53 (DO-1), anti-Mdm2 (4B2), for Mdm2-mediated NEDDylation of p53, three different
sets of p53 lysine mutants were employed: the 3NKRanti-NEDD8, or control IgG antibodies. DO-1 and 4B2
immunoprecipitates were analyzed by Western blotting (K370R, K372R, K373R), the 3CKR (K381R, K382R,
K386R), and the 6KR (with all six lysines mutated intousing a polyclonal anti-NEDD8 antibody, whereas the
reciprocal analysis was performed with the anti-NEDD8 arginines). These mutants were either expressed alone
or coexpressed with Mdm2 in the presence of eitherimmunoprecipitates. As shown in Figure 3E, a species
of the predicted molecular weight for p53 modified with His6-ubiquitin or His6-NEDD8. Comparison of Mdm2-
mediated ubiquitination with NEDDylation of these p53a single NEDD8 moiety was observed both in the DO-1
and anti-NEDD8 lane but not in the control IgG lanes. mutants identified key differences in the lysine require-
ments for these two pathways (Figure 4A). ConsistentSimilarly, for Mdm2, a specific band was detected above
the 116 KD marker in the 4B2 and anti-NEDD8 immuno- with previous reports, mutation of six lysines in the C
terminus of p53 (6KR mutant) was necessary to abrogateprecipitates but not in the control lanes (Figure 3F). This
size corresponds to the predominant Mdm2 species Mdm2-mediated ubiquitination and degradation of p53.
However, Mdm2-mediated NEDDylation of p53 ap-detected in the overexpression experiment described
in Figure 1B. These data strongly suggest that both peared to depend on lysines K370, K372, and K373,
as NEDDylation of the 3NKR mutant was substantiallyendogenous p53 and Mdm2 are modified with NEDD8.
reduced (Figure 4A). Importantly, like Mdm2-mediated
ubiquitination of p53, NEDD8 conjugation was depen-Specificity of Mdm2 as an E3 Ligase for p53
Mdm2 protein belongs to the RING finger family of li- dent on the direct interaction of p53 with Mdm2, as the
F19A p53 mutant, which is deficient for Mdm2 bindinggases, and transfer of ubiquitin to itself and to p53 de-
pends on the RING finger domain of the protein. To (Liu et al., 2001; Xirodimas et al., 2001b), was also defi-
cient for NEDDylation. Individual p53 lysine mutantsdetermine if the ability of Mdm2 to promote ubiquitin
Figure 2. Mdm2 Promotes NEDDylation of p53 In Vivo
(A) H1299 cells were transfected with 1 g of p53, 2 g of Mdm2, and 2 g of His6-NEDD8 expression constructs as indicated. His6-NEDDylated
species were purified as before and analyzed by Western blotting with DO-1 anti-p53 monoclonal antibody (top panel). Total levels of p53
are shown on the bottom panel.
(B) H1299 cells were transfected as before, and, where indicated, 5 g of NEDD8-specific protease NEDP1, SSP3 SUMO protease, or 2 g
of His6-NEDD8, His6-SUMO-1, His6-Ubiquitin expression constructs were included.
(C) H1299 cells were transfected as above, and, where indicated, the p53-specific deubiquitinating enzyme HAUSP and its catalytic inactive
mutant (HAUSP Cys) expression constructs were cotransfected. Modified p53 (top panel) and total p53 (bottom panel) were detected with
the DO-1 anti-p53 antibody.
(D) H1299 cells were first transfected with control or Hdm2 siRNA (200 nM) and then with p53 and His6-NEDD8 as described in Experimental
Procedures. Cells were harvested and analyzed as before for NEDDylated and total p53.
(E) Wild-type p53 or F19A mutant was transfected in the absence or presence of His6-NEDD8 and increasing amounts of STIP as indicated.
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Figure 3. In Vitro NEDDylation of p53
(A) Reactions were performed as described in Experimental Procedures. Samples were analyzed by Western blotting with DO-1 anti-p53
monoclonal antibody. (B) Signals in each lane (A) were quantitated and expressed as increase in arbitrary units over background (no added
NEDD8 lane). (C) In vitro reactions were performed as in (A), using 100 ng of Ubc12 in each reaction and increasing amounts of bacterially
expressed Mdm2. (D) Signals (in [C]) were quantitated and expressed as increase in arbitrary units over background (no Mdm2 added).
Ubiquitination assay was performed as described in Experimental Procedures. Endogenous p53 and Mdm2 are modified with endogenous
NEDD8. (E) Cells (5  107 COS-1) were harvested and lysed and immunoprecipitated as described in Experimental Procedures with anti-
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Figure 4. Mdm2-Mediated NEDDylation of p53 Requires Lysines K370, K372, and K373 in the C Terminus of p53
(A) H1299 cells were transfected with wild-type (wt) p53 or p53 lysine mutants, 3NKR (K370R, K372R, and K373R), 3CKR (K381R, K382R, and
K386R), or 6KR (all six lysines mutated into arginine). Where indicated, 2 g of Mdm2 and 2 g of His6-ubiquitin (U) or His6-NEDD8 (N) were
cotransfected. Ni2-agarose eluates and cell extracts were analyzed by Western blotting using the DO-1 anti-p53 antibody (top and middle
panels). Equal transfection efficiency and loading are demonstrated by -gal expression (lower panel, 1 g of DNA was cotransfected).
(B) Specific transcriptional activity of wild-type p53 and p53 lysine mutants. Increasing amounts of p53 expression constructs were transfected
in H1299 cells. Transcriptional activity was measured 24 hr posttransfection as described in Experimental Procedures. The same cell extracts
were used to monitor the stability of wild-type p53 and p53 lysine mutants by two-site ELISA as described before (Xirodimas et al., 2001a).
The presented data is the ratio of the transcriptional activity to protein levels (specific activity). Renilla was used to normalize the values in
both assays.
were also used, but no differences were observed in Previous analysis of p53 lysine mutants in the C termi-
nus of p53 showed that they exhibit higher transcrip-Mdm2-mediated ubiquitination or NEDDylation of these
mutants (data not shown). tional activity than wild-type p53 (Rodriguez et al., 2000).
NEDD8 polyclonal, DO-1 anti-p53 monoclonal antibody, or IgG control. Immunoprecipitates were analyzed by Western blotting with anti-
NEDD8polyclonal antibody or DO-1 anti-p53 as indicated. (F) Cells (5 107 H1299) or SJSA were lysed as before and used for immunoprecipita-
tions with anti-NEDD8, 4B2 anti-Mdm2, or IgG control antibodies. Immunoprecipitates were Western blotted with 4B2 or anti-NEDD8 antibodies
as indicated. (G) Specificity of Mdm2 as an E3 ligase. H1299 cells were transfected with 1 g of wild-type p53, 2 g of Mdm2, and 2 g of
each of the His6-tagged expression constructs. After 36 hr, His6-tagged conjugated species were purified as before and analyzed by Western
blotting using the DO-1 anti-p53 antibody (top panel). The lower panel shows total levels of p53.
Cell
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The observed differences in the lysine requirements be- conjugation inhibits the transcriptional activity of p53.
Furthermore, changes were observed in the ability oftween ubiquitination and NEDDylation of p53 prompted
us to reexamine the transcriptional activity of these mu- Mdm2 to inhibit the transcriptional activity of p53. In
wild-type CHO cells, temperature shift abrogated thetants. H1299 cells were transfected with the indicated
amounts of DNA for each p53 construct along with inhibitory effect of Mdm2 on the activity of p53. However,
in TS-41 cells, Mdm2 appeared to suppress p53 activityPG13-luc plasmid, in which a p53 response element
drives the expression of luciferase. The same cell ex- more efficiently at the restrictive temperature (39C) (Fig-
ure 5C). Cell extracts from a replica experiment weretracts were also analyzed by two-site ELISA to deter-
mine the amount of p53 protein in the same experiment. also used to monitor the expression levels of Mdm2 and
p53 proteins (Figure 5D). Temperature shift to 39C inThe ratio of the transcriptional activity to the protein
levels of wild-type p53 and the p53 mutants will indicate the TS-41 cells appeared to increase both the levels of
Mdm2 and p53 proteins. However, under these condi-the specific activities of the proteins and whether these
mutations affect the intrinsic transcriptional activity of tions, Mdm2 efficiently decreased the levels of p53. The
opposite phenotype was observed in the wild-type CHOp53. As shown in Figure 4B, all p53 mutants tested
displayed an increased specific transcriptional activity cell line. Temperature shift to 39C decreased the levels
of Mdm2, and p53 appeared resistant to Mdm2-medi-compared with wild-type p53. However, whereas the
6KR and 3CKR mutant were very similar, the 3NKR mu- ated degradation. This is consistent with the observation
that Mdm2 suppressive effect on p53 transcriptionaltant showed an intermediate phenotype between wild-
type p53 and the 6KR/3CKR mutants. The increased activity was inhibited in the wild-type CHO cells at 39C.
To determine whether the effects on p53 transcrip-transcriptional activity of the 3NKR mutant, compared
to wild-type protein, suggests that NEDD8 modification tional activity in the TS-41 cells were due to mutation
in the APP-BP1 gene, we performed the transcriptionalof p53 inhibits its transcriptional activity. This compari-
son also differentiates the role of these two sets of lysine assays described above in the presence of coexpressed
wild-type APP-BP1. A titration of increasing amountsresidues in the control of the intrinsic transcriptional
activity of p53. of transfected APP-BP1 construct showed that, at low
concentrations, wild-type APP-BP1 could rescue the
p53 transcriptional phenotype observed at 39C (FigureMutation of a E1-NEDD8 Component (APP-BP1)
5E). As shown before, Mdm2 at the restrictive tempera-Increases the Transcriptional Activity of p53
ture dramatically reduced the transcriptional activity ofand Facilitates the Inhibitory Effect
p53. However, coexpression of wild-type APP-BP1 re-of Mdm2 on p53-Dependent Transcription
versed the effect of Mdm2 on p53 function, restoringTo test the biological significance of NEDD8 conjugation
the phenotype observed at 32C. Expression of APP-of p53, we used a previously described cell line (CHO-
BP1 alone reduced the activity of p53, restoring theTS-41) that contains a temperature-sensitive mutation
phenotype observed at 32C. These data strongly sug-in the APP-BP1 gene (Cernac et al., 1997). The gene
gest that the differences observed in p53 activity andproduct interacts with Uba3 to form a heterodimeric
Mdm2 function at 39C were due to mutation of the E1complex, which acts as the E1-activating enzyme for
NEDD8 component APP-BP1.NEDD8. This biological system has been widely used to
demonstrate the effect of NEDD8 conjugation pathway
on the function of SCF E3 ubiquitin ligases (Chen et al., The NEDD8 Conjugation Pathway Requires
Lysines K370, K372, and K373 in p532000; Querido et al., 2001; Ohh et al., 2002; Bloom et
al., 2003). In our study, by growing these cells at the to Regulate p53 Transcriptional Activity
The transcriptional data obtained using the TS-41 cellrestrictive temperature (39C), we could specifically
study the effect of the NEDD8 conjugation pathway on line demonstrated that NEDD8 conjugation controls
both p53 and Mdm2 function. Our mutational analysisp53 stability/activity. Indeed, as shown in Figure 5A
(lanes 2 and 5), when the TS-41 cells were grown at on p53 demonstrated that lysines K370, K372, and K373
in p53 are required for Mdm2-mediated NEDDylation of32C, Mdm2 could efficiently promote conjugation of
ubiquitin and NEDD8 to p53. However, at 39C, NEDD8 the protein. This p53 mutant, in combination with the
TS-41 cell line where the NEDD8 conjugation pathwayconjugation of p53 was dramatically reduced (Figure 5A,
compare lanes 5 and 11), while ubiquitination was not can be selectively switched off, provides the tools to (1)
demonstrate that the increased transcriptional activityaffected (Figure 5A, compare lanes 2 and 8). This sug-
gests that the NEDD8 conjugation pathway does not of p53 at the restrictive temperature in the TS-41 cells
is due to lack of NEDDylation of p53 and not to lack ofregulate Mdm2-mediated ubiquitination of p53. There-
fore, we used this system to determine the effect of NEDDylation of cullins or other yet unidentified NEDD8
substrates; and (2) to differentiate the effect of NEDD8NEDD8 conjugation on the transcriptional activity of p53.
TS-41 and the wild-type CHO cells were transfected modification on the transcriptional activity of p53 and
the ability of Mdm2 to suppress p53-dependent tran-with wild-type p53 alone or with increasing amounts of
Mdm2 expression construct along with the PG13-luc scription. Wild-type p53 and the 3NKR p53 mutant were
expressed in TS-41 or wild-type CHO cells. As before,reporter plasmid. Cells were then either kept at 32C or
shifted to 39C for a further 24 hr, and cell extracts were cells were kept at 32C or shifted to 39C, and p53
transcriptional activity was measured 24 hr later. Asanalyzed for p53 activity. Temperature shift increased
the activity of p53 in the TS-41 cells, whereas no signifi- shown before, a shift of the TS-41 cells to the nonpermis-
sive temperature increased the transcriptional activitycant changes were observed in the wild-type CHO cells
(Figure 5B). This is consistent with the idea that NEDD8 of wild-type p53. However, the 3NKR mutant, which is
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resistant to Mdm2-mediated NEDDylation, displayed an quired for Mdm2-dependent NEDDylation. This evi-
dence demonstrates a key role for Mdm2 in p53 NEDDy-increased transcriptional activity at the permissive tem-
perature, and shift to 39C did not significantly increase lation and strongly suggests that Mdm2 acts as an E3
NEDD8 ligase.its activity (Figure 6A). This strongly suggests that the
increase in p53 activity in the TS-41 cells at the restric- Using p53 as a substrate, Mdm2 was limited to the
conjugation of ubiquitin and NEDD8 but not SUMO-1 ortive temperature is due to lack of p53 NEDDylation. We
also used the 3NKR mutant to investigate the role of ISG15. In the other characterized system for NEDD8
conjugation, Rbx1, the RING finger component of thethe NEDD8 conjugation pathway in the activity of Mdm2
as a suppressor of p53 activity. Wild-type p53 and the SCF complex, which is required for ubiquitin ligase activ-
ity, can also act an E3 NEDD8 ligase for cullins (see3NKR mutant were expressed either alone or with in-
creasing amounts of Mdm2 in the TS-41 cells at the Introduction). These observations raise the possibility
that the dual usage of ubiquitin and NEDD8 could be apermissive and restrictive temperature. The 3NKR mu-
tant appeared to resist transcriptional repression by common feature of the RING finger type of E3 ligases.
Mdm2 compared with wild-type p53 at 32C in TS-41
cells (Figure 6B). However, at 39C, Mdm2 could effi- Modification with NEDD8 Inhibits
ciently suppress the activity of the 3NKR mutant in a the Transcriptional Activity of p53
very similar manner to that of wild-type p53 suppression. The data presented in this study demonstrate a role for
These data provide evidence that the NEDD8 conjuga- NEDD8 conjugation of p53 as a mechanism of control
tion pathway also controls the ability of Mdm2 to sup- of p53 transcriptional activity. Mdm2-mediated NEDDy-
press p53 function. lation of p53 requires three lysines (K370, K372, and
K373) at the C terminus of the protein (3NKR p53 mu-
Differential Regulation of p53 Ubiquitination tant). Earlier reports demonstrated that lysines K370,
and NEDDylation by UV-Induced DNA Damage K372, K373, K381, K382, and K386, located in the C
The stability of the p53 protein is subject to regulation terminus of p53, are required for Mdm2-mediated ubi-
by a variety of stress stimuli, including DNA damage quitination and proteasomal degradation of p53. This
induced by 	 rays (IR) or UV light. To determine the group includes the lysines that are required for NEDD8
effect of DNA damage on modification of endogenous modification, but the clear difference in the lysine re-
p53 with NEDD8 or ubiquitin, we used MCF7 cells, which quirement for NEDD8 and ubiquitin conjugation of p53
contain wild-type p53 and had been established to ex- indicates the differential specificity of Mdm2 for these
press either His6-NEDD8 or His6-ubiquitin. As control, two conjugation pathways. The 3NKR mutant displayed
we used parental MCF7 cells, which do not express an increased transcriptional activity compared to wild-
tagged NEDD8 or ubiquitin. Cells were irradiated with type p53 in H1299 cells, suggesting that NEDDylation
UV, and, 4 or 8 hr postirradiation, His6-NEDDyalted or of p53 inhibits its function.
His6-ubiquitinated species were purified as before and The use of the TS-41 CHO cell line provided a good
analyzed for p53 modification by Western blotting. As biological system to assess the biological significance
shown in Figure 7A, endogenous p53 is modified both of the NEDD8 conjugation pathway in the transcriptional
with ubiquitin and NEDD8 (UV, 0 hr). UV treatment re- activity and stability of p53. At the restrictive tempera-
sulted in increased p53 protein levels in all three sys- ture where the NEDD8 conjugation pathway is impaired
tems. Ubiquitin modification of p53 was inhibited 4 hr (Figure 5A), the transcriptional activity of p53 was in-
post-UV treatment and sustained 8 hr after irradiation. creased, and the levels of p53 protein were moderately
NEDD8 modification of p53 was transiently increased 4 elevated (Figure 5B, 5D no Mdm2 cotransfection lane),
hr after UV irradiation but could not be detected by 8 consistent with a suppressive role for NEDD8 conjuga-
hr post-UV irradiation. NEDD8 modification and ubiquiti- tion for p53 activity. The 3NKR p53 mutant, which is
nation of p53 therefore displayed different kinetics in deficient for Mdm2-mediated NEDDylation, displayed
response to UV irradiation. These data show that p53 an increased transcriptional activity compared to wild-
NEDDylation, like ubiquitination, is subject to DNA dam- type p53 at 32C with no dramatic increase upon temper-
age response signals controlling p53 activity, but these ature shift. This demonstrates that direct NEDDylation
p53 modifications are differentially controlled. of p53 can control p53 transcriptional activity.
The use of proteases that specifically remove ubiqui-
tin, NEDD8, or SUMO-1 provided a powerful tool to in-Discussion
vestigate the different modifications of p53. The specific
deubiquitinating p53 enzyme HAUSP rescued p53 fromMdm2 Promotes Ubiquitin and NEDD8
Modification of p53: A Common Feature Mdm2-mediated degradation. Under these conditions,
HAUSP prevented the formation of high molecularfor RING Finger Ligases?
In this paper, we demonstrate that the Mdm2 RING fin- weight p53 species in the NEDD8 Ni2 pull-down, sug-
gesting that these species are ubiquitin conjugates andger E3-ubiquitin ligase is NEDDylated and promotes
conjugation of NEDD8 to p53. While in vitro Mdm2 could that p53 could be simultaneously modified with NEDD8
and ubiquitin. However, while HAUSP dramatically in-produce a moderate stimulation on NEDD8 modification
of p53, the in vivo data demonstrate that p53 NEDDyla- creased p53 protein levels in the presence of Mdm2
(Figure 2C, bottom panel), there was no significant in-tion depends on Hdm2 expression and direct binding
of p53 to H(M)dm2. Also, the critical cysteine C462 in crease in the p53 levels upon expression of the de-
NEDDylating enzyme NEDP1 (Figure 2B, lanes 2 and 3).the RING finger domain of the protein, which is required
for the E3 ubiquitin ligase activity of Mdm2, is also re- This suggests that NEDD8 modification of p53 does not
Cell
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Figure 5. The NEDD8 Pathway Controls the Function of p53 and Mdm2
(A) Mdm2-mediated NEDDylation of p53 is impaired at 39C in TS-41 cells. TS-41 cells, where indicated, were transfected with 1 g of p53,
2 g of Mdm2, 2 g of His6-ubiquitin (His6-Ub), or His6-NEDD8 expression constructs. Cells were either kept at 32C or shifted to 39C and
24 hr later His6-ubiquitinated, or His6-NEDDylated species were purified as described before. Samples were analyzed for p53 modification by
Western blotting using the DO-1 monoclonal antibody. (B) Wild-type p53 expression construct (10 ng) was transfected either alone or with
increasing amounts of Mdm2 (C) as indicated in TS-41 or wild-type CHO cells. The next day, cells were either kept at 32C or shifted to 39C,
Mdm2 Promotes NEDD8 Conjugation of p53
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Figure 6. The NEDD8 Conjugation Pathway
Requires Lysines K370, K372, and K373 in
p53 to Control its Transcriptional Activity
(A) Wild-type p53 or 3NKR lysine mutant (10
ng) were transfected in TS-41 and wild-type
CHO cells. Cells were either kept at 32C or
shifted to 39C, and p53 transcriptional activ-
ity was measured 24 hr later.
(B) The NEDD8 conjugation pathway controls
the suppressive effect of Mdm2 on p53 tran-
scriptional activity. Wild-type p53 or 3NKR
lysine mutant (10 ng) were transfected in TS-
41 cells either alone or with increasing amounts
of Mdm2 expression construct. Temperature
shift and measurement of p53 transcriptional
activity was performed as before. Values are
expressed as percentage changes in activity.
(C) Schematic representation of the NEDD8
modification status for p53 and Mdm2 in the
above experiment.
have a significant effect on Mdm2-mediated degrada- of the transcriptional activity of p53 (Figure 5C). The
observation that temperature shift also resulted in in-tion of p53.
creased Mdm2 protein levels in TS-41 cells (Figure 5D)
may explain Mdm2’s increased capacity to suppressNEDD8 Conjugation Pathway Inhibits the
Suppressive Role of Mdm2 on p53 Function p53 function under these conditions. These data sug-
gest that NEDD8 conjugation also suppresses the inhibi-The use of the TS-41 CHO cell line also demonstrated
the role of NEDD8 modification on Mdm2 function as tory role of Mdm2 on p53 function.
The use of the 3NKR mutant in the TS-41 cell linean inhibitor of p53 transcriptional activity. In wild-type
CHO cells, Mdm2’s ability to suppress p53 function was provided a good approach to differentiate the role of
NEDD8 modification in the activity of p53 and Mdm2.inhibited upon temperature shift to 39C (Figure 5C). This
could be due to heat stress, which may block Mdm2- This mutant is impaired for Mdm2-mediated NEDDyla-
tion, so we could specifically address the role of NEDD8mediated suppression of p53. However, this effect was
clearly reversed in the TS-41 cells at the restrictive tem- conjugation on the ability of Mdm2 to inhibit p53 func-
tion. At conditions where the NEDD8 conjugation path-perature, and Mdm2 appeared to be a better inhibitor
and p53 transcriptional activity was measured 24 hr later. (D) Cells from a replica experiment were lysed with 2  SDS buffer and analyzed
by Western blotting for p53 and Mdm2 protein levels. Loading was monitored by actin. It has to be noted that, for each protein, the same
exposure time was employed, but different exposure times were used between different cell lines. Therefore, no comparison of protein levels
should be made between different cell lines. (E) Expression of wild-type APP-BP1 rescues the phenotype of the TS-41 cells at 39C. TS-41
cells were transfected with 10 ng of p53; 10 ng of Mdm2; and 20, 50, 100, and 200 ng of APP-BP1 expression constructs as indicated. Cells
were shifted to 39C, and p53 transcriptional activity was measured 24 hr later. When p53 and APP-BP1 were coexpressed, 200 ng of APP-
BP1 expression construct was used.
Cell
94
Figure 7. Differential Regulation of Ubiquitin and NEDD8 Modification of p53 upon UV-Induced DNA Damage
(A) Control MCF7 or MCF7 cells stably expressing either His6-ubiquitin or His6-NEDD8 were irradiated with UV (30 joules/m2). At the indicated
time points, His6-tagged conjugates were purified as before, and eluates were used for Western blotting with the DO-1 anti-p53 antibody.
Modification of endogenous p53 with ubiquitin or NEDD8 is shown on the top panel. The bottom panel shows total levels of endogenous p53
in that experiment.
(B) A model for the role of the NEDD8 conjugation pathway as a negative regulator of p53 and Mdm2 function. Mdm2 protein promotes
NEDDylation (Nd) of p53 and itself. The NEDD8 conjugation pathway inhibits both the transcriptional activity of p53 and the suppressive effect
of Mdm2 on p53 function. In this way, Mdm2 negatively controls the function of p53 and itself through the same pathway.
(C) Mdm2 at the center of ubiquitin (Ub) and NEDD8 (Nd) conjugation pathways. Diversity for the regulation of Mdm2 and p53 function.
way is active (32C), the NEDDylation-deficient p53 is also the role of ubiquitin conjugation as it negatively
regulates p53 and Mdm2 proteins by targeting them formutant (3NKR) was resistant to Mdm2-mediated sup-
pression. This resistance was clearly inhibited at the proteasomal degradation.
Previous reports have suggested a link between therestrictive temperature (39C), where the NEDD8 conju-
gation pathway is switched off, thus demonstrating that NEDD8 conjugation pathway and p53 function. The
COP9 signalosome (CSN) was shown to phosphorylatethe NEDD8 pathway also controls the inhibitory effect
of Mdm2 on p53 function. p53 and control its proteasomal degradation by the E6/
AP and Mdm2 pathway (Bech-Otschir et al., 2001). Mice,The data support a model where both p53 and Mdm2
are subjects of a negative regulation by the NEDD8 con- in which the genes encoding for the COP9 signalosome
subunits 2 and 3 (Csn2, Csn3) were disrupted, showedjugation pathway (Figure 7B). Mdm2 protein by promot-
ing NEDD8 modification negatively regulates the func- deficiencies in cell proliferation and increase in p53 and
cyclin E protein levels (Lykke-Andersen et al., 2003; Yantion of p53 and itself through the same pathway. This
Mdm2 Promotes NEDD8 Conjugation of p53
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Purification of His6-Tagged Conjugateset al., 2003). Furthermore, the NEDD8 conjugation path-
Posttransfection cells (36 hr) were harvested, and His6-tagged con-way was implicated in p53 degradation by adenovirus
jugates were purified as described before (Rogriguez et al., 1999;E4orf6 and E1B55K proteins (Querido et al., 2001). The
Xirodimas et al., 2001a). Twenty percent of cells were used for
discovery that Mdm2 E3 ubiquitin ligase can also stimu- NP-40 lysis, and Western blotting was performed as described in
late the conjugation of p53 and itself to NEDD8 provides Xirodimas et al. (2001a).
direct evidence for a functional link between the NEDD8
conjugation pathway and regulation of p53 and Mdm2
In Vitro NEDDylation Assaysfunction.
SF9 cells were infected with viruses kindly provided by Dr Kazuhiro
Iwai, expressing His-tagged APP-BP1 and T7-tagged Uba3. The E1
NEDD8 activating heterodimer enzyme was purified from extractsMdm2 at the Center of Ubiquitin and NEDD8
using Ni2-NTA agarose. GST-Ubc12 was expressed in bacteria,Conjugation Pathways: Diversity for RING
and, after purification through glutathione sepharose beads, theFinger Ligases as Regulators of Protein Function
GST was cleaved with thrombin. Thrombin and any free GST were
The discovery that Mdm2 can use both the ubiquitin removed with benzamidine and glutathionine sepharose beads, re-
and NEDD8 conjugation pathways positions it at the spectively. Mdm2 and p53 proteins were expressed in bacteria.
center of these two pathways (Figure 7C). However, the Mdm2 was purified from inclusion bodies, whereas p53 in the solu-
ble fraction was partially purified using a heparin column (Phar-observation that Mdm2-mediated ubiquitination of p53
macia). p53 (40 ng) was incubated in a 15 l reaction including anwas not affected at conditions where Mdm2-mediated
ATP regenerating system (50 mM Tris [pH 7.5], 5 mM MgCl2, 2 mMNEDDylation of p53 could be inhibited (39C in TS-41
ATP, 10 mM creatine phosphate, 3.5 U/ml creatine kinase, and 0.6
cells, Figure 5A), suggests the independent regulation U/ml inorganic pyrophosphatase), 120 ng of NEDD8 activating en-
of the ability of Mdm2 to promote ubiquitin and NEDD8 zyme (APP-BP1/Uba3), the indicated amounts of Ubc12 and Mdm2
conjugation to p53. It also indicates that the E3 ubiquitin proteins, and 5 g of NEDD8. The reactions were incubated at 37C
for 2 hr and then terminated with 2  SDS sample buffer containingligase activity of Mdm2 is not controlled through NEDDy-
-mercaptoethanol. The samples were fractionated in 10% Novexlation of cullins, the other well-characterized substrate
gels and analyzed by Western blotting for p53 using the DO-1 mono-for NEDD8 modification. The differential pattern of ubi-
clonal antibody. For the ubiquitination assay, 50 ng of E1 activating
quitin and NEDD8 modification of endogenous p53 after enzyme, 200 ng of UbcH5a, and 150 ng of Mdm2 were used in the
UV-induced DNA damage shows that NEDD8 modifica- NEDDylation reaction buffer.
tion is part of p53 activity control and further supports
the idea that these two conjugation pathways are differ-
Immunoprecipitationsentially regulated. The dual role of Mdm2 in the ubiquitin
Cells (5  107 COS-1, H1299, SJSA) were lysed in 750 l of PBSand NEDD8 conjugation pathways suggests a highly
containing 1% NP-40, 1% SDS, 5 mM EDTA, 10 mM iodoacetamide,
controlled system for Mdm2 function and also indicates and Protease Inhibitor Cocktail (Roche). After lysis, extracts were
the diversity of E3 ligases as regulators of protein incubated at 60C for 10 min, and 10 mM of DTT was added, diluted
function. 10 times with PBS-NP-40, and precleared with 200 l of protein G
beads (50% slurry) for 45 min at 4C. For each immunoprecipitation,
5 g of DO-1 or IgG and 10 l of 4B2 ascites or anti-NEDD8 serumExperimental Procedures
were used, and samples were incubated for 3 hr at 4C. Fifty percent
slurry protein G beads (20 l) were then added, and samples wereAntibodies and Chemicals
rotated at 4C for 45 min. Beads were washed five times with 500p53 and Mdm2 were detected using the DO-1 and 4B2 mouse mono-
l of PBS-NP-40, and 20 l of 2  SDS loading buffer was added.clonal antibodies, respectively (Stephen et al., 1995; Chen et al.,
Immunoprecipitates were analyzed by Western blotting as indi-1993). The anti-NEDD8 rabbit polyclonal antibody and NEDD8 pro-
cated.tein were purchased from Alexis Biochemicals. Anti--gal and anti-
actin mouse monoclonal antibodies were purchased from Onco-
gene. MG132 was purchased from Calbiochem and iodoacetamide
Transcriptional and Temperature Shift Experimentsfrom Sigma. siRNAs were purchased from Dharmacon.
In a 24-well plate, 45,000 cells/well were seeded and transfected
using FuGENE 6. p53 (10 ng), 50 ng of PG-13-luciferase, and 1 ng
Cell Culture and Transfections of Renilla expression constructs were used in each transfection.
All cell lines were grown in medium with 10% fetal bovine serum. The total amount of transfected plasmid was made up to 300 ng
H1299 cells were grown in RPMI, CHO, and TS-41 cells in F12 with empty pcDNA3 vector. The cells were incubated at 32C over-
CHO cell line medium, and COS-1 in DMEM. All transfections were night and were either shifted to 39C or kept at 32C for a further
performed using FuGENE 6 according to manufacturer’s instruc- 24 hr. Cells were lysed with 1  passive lysis buffer (Promega), and
tions, except for the experiments in H1299 cells, where the calcium luciferase and Renilla activities were measured using the Berthold
phosphate method was used in 10 cm tissue culture plates. For the Microplate Luminometer LB 96V. Renilla values were used to control
siRNA experiment, 2  105 H1299 cells were plated in 6-well dishes transfection efficiency and cell death.
and transfected with siRNA (200 nM) by oligofectamine. Next-day
cells were reseeded, transfected the day after with p53 (0.5 g) and
His6-NEDD8 (1 g) by using FuGENE 6, and harvested 24 hr later. Two-Site ELISA
Stability of p53 was monitored by two-site ELISA as described in
Plasmids Xirodimas et al. (2001a).
Human NEDD8 and ISG15 were amplified from fetal human liver
cDNA and cloned in frame with His6 in pcDNA3 vector. Ubc12 cDNA
was received as an IMAGE clone from Research Genetics/Incyte Acknowledgments
Genomics (ID 3344837). The Ubc12 cDNA was amplified and cloned
in the pGEX-2TK vector (Pharmacia). All sequences were confirmed We would like to thank Dr. Rachel Neve and Dr. Yuzhi Chen for
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2000) was kindly provided by Dr. Rachel Neve. All other plasmids wild type APP-BP1; and Dr. Kazuhiro Iwai for providing us with
baculovirus expressing His-tagged APP-BP1 and T7-tagged Uba3are described elsewhere (Rodriguez et al., 1999; Xirodimas et al.,
2001a, 2002). proteins. This work is supported by Cancer Research UK.
Cell
96
Received: December 2, 2003 NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J. 20, 4003–
4012.Revised: May 28, 2004
Accepted: June 4, 2004 Kondo, K., and Kaelin, W.G., Jr. (2001). The von Hippel-Lindau tumor
Published: July 8, 2004 suppressor gene. Exp. Cell Res. 264, 117–125.
Kubbutat, M.H., Jones, S.N., and Vousden, K.H. (1997). Regulation
References of p53 stability by Mdm2. Nature 387, 299–303.
Kurz, T., Pintard, L., Willis, J.H., Hamill, D.R., Gonczy, P., Peter, M.,Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B.,
and Bowerman, B. (2002). Cytoskeletal regulation by the Nedd8Pollmann, C., and Dubiel, W. (2001). COP9 signalosome-specific
ubiquitin-like protein modification pathway. Science 295, 1294–phosphorylation targets p53 to degradation by the ubiquitin system.
1298.EMBO J. 20, 1630–1639.
Lain, S. (2003). Protecting p53 from degradation. Biochem. Soc.Bloom, J., and Pagano, M. (2003). Deregulated degradation of the
Trans. 31, 482–485.cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol.
Lammer, D., Mathias, N., Laplaza, J.M., Jiang, W., Liu, Y., Callis, J.,13, 41–47.
Goebl, M., and Estelle, M. (1998). Modification of yeast Cdc53p byBloom, J., Amador, V., Bartolini, F., DeMartino, G., and Pagano,
the ubiquitin-related protein rub1p affects function of the SCFCdc4M. (2003). Proteasome-mediated degradation of p21 via N-terminal
complex. Genes Dev. 12, 914–926.ubiquitinylation. Cell 115, 71–82.
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A.Y., Qin, J., andBottger, A., Bottger, V., Sparks, A., Liu, W.L., Howard, S.F., and
Gu, W. (2002). Deubiquitination of p53 by HAUSP is an importantLane, D.P. (1997). Design of a synthetic Mdm2-binding mini protein
pathway for p53 stabilization. Nature 416, 648–653.that activates the p53 response in vivo. Curr. Biol. 7, 860–869.
Liakopoulos, D., Doenges, G., Matuschewski, K., and Jentsch, S.Cernac, A., Lincoln, C., Lammer, D., and Estelle, M. (1997). The SAR1
(1998). A novel protein modification pathway related to the ubiquitingene of Arabidopsis acts downstream of the AXR1 gene in auxin
system. EMBO J. 17, 2208–2214.response. Development 124, 1583–1591.
Liu, W.L., Midgley, C., Stephen, C., Saville, M., and Lane, D.P. (2001).Chen, J., Mavechal, V., and Levine, A.J. (1993). Mapping of the p53
Biological significance of a small highly conserved region in the Nand mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107–4114.
terminus of the p53 tumour suppressor protein. J. Mol. Biol. 313,
Chen, Y., McPhie, D.L., Hirschberg, J., and Neve, R.L. (2000). The
711–731.
amyloid precursor protein-binding protein APP-BP1 drives the cell
Liu, J., Furukawa, M., Matsumoto, T., and Xiong, Y. (2002). NEDD8cycle through the S-M checkpoint and causes apoptosis in neurons.
modification of CUL1 dissociates p120(CAND1), an inhibitor ofJ. Biol. Chem. 275, 8929–8935.
CUL1-SKP1 binding and SCF ligases. Mol. Cell 10, 1511–1518.
Ciechanover, A. (1998). The ubiquitin-proteasome pathway: on pro-
Lykke-Andersen, K., Schaefer, L., Menon, S., Deng, X.W., Miller,tein death and cell life. EMBO J. 17, 7151–7160.
J.B., and Wei, N. (2003). Disruption of the COP9 signalosome Csn2
Deshaies, R.J. (1999). SCF and Cullin/Ring H2-based ubiquitin li-
subunit in mice causes deficient cell proliferation, accumulation
gases. Annu. Rev. Cell Dev. Biol. 15, 435–467.
of p53 and cyclin E, and early embryonic death. Mol. Cell. Biol.
Everett, R.D., Meredith, M., Orr, A., Cross, A., Kathoria, M., and 23, 6790–6797.
Parkinson, J. (1997). A novel ubiquitin-specific protease is dynami-
Mendoza, H.M., Shen, L.N., Botting, C., Lewis, A., Chen, J., Ink, B.,
cally associated with the PML nuclear domain and binds to a herpes-
and Hay, R.T. (2003). NEDP1, a highly conserved cysteine protease
virus regulatory protein. EMBO J. 16, 1519–1530.
that deNEDDylates Cullins. J. Biol. Chem. 278, 25637–25643.
Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H., and Weissman,
Mendrysa, S.M., McElwee, M.K., Michalowski, J., O’Leary, K.A.,
A.M. (2000). Mdm2 is a RING finger-dependent ubiquitin protein
Young, K.M., and Perry, M.E. (2003). mdm2 is critical for inhibition
ligase for itself and p53. J. Biol. Chem. 275, 8945–8951.
of p53 during lymphopoiesis and the response to ionizing irradiation.
Gong, L., and Yeh, E.T. (1999). Identification of the activating and Mol. Cell. Biol. 23, 462–472.
conjugating enzymes of the NEDD8 conjugation pathway. J. Biol.
Michael, D., and Oren, M. (2003). The p53-Mdm2 module and the
Chem. 274, 12036–12042.
ubiquitin system. Semin. Cancer Biol. 13, 49–58.
Gray, W.M., Hellmann, H., Dharmasiri, S., and Estelle, M. (2002).
Midgley, C.A., Destero, J.M.P., Saville, M.K., Howard, S., Sparks,
Role of the Arabidopsis RING-H2 protein RBX1 in RUB modification
A., Hay, R.T., and Lane, D.P. (2000). An N-terminal p14ARF peptide
and SCF function. Plant Cell 14, 2137–2144.
blocks Mdm2-dependent ubiquitination in vitro and can activate
Handeli, S., and Weintraub, H. (1992). The ts41 mutation in Chinese p53 in vivo. Oncogene 19, 2312–2323.
hamster cells leads to successive S phases in the absence of in-
Montes de Oca Luna, R., Wagner, D.S., and Lozano, G. (1995).
tervening G2, M, and G1. Cell 13, 599–611.
Rescue of early embryonic lethality in mdm2-deficient mice by dele-
Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes tion of p53. Nature 378, 203–206.
the rapid degradation of p53. Nature 387, 296–299.
Morimoto, M., Nishida, T., Nagayama, Y., and Yasuda, H. (2003).
Honda, R., Tanaka, H., and Yasuda, H. (1997). Oncoprotein MDM2 Nedd8-modification of Cul1 is promoted by Roc1 as a Nedd8-E3
is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, ligase and regulates its stability. Biochem. Biophys. Res. Commun.
25–27. 301, 392–398.
Honda, R., and Yasuda, H. (2000). Activity of MDM2, a ubiquitin Nakamura, S., Roth, J.A., and Mukhopadhyay, T. (2000). Multiple
ligase, toward p53 or itself is dependent on the RING finger domain lysine mutations in the C-terminal domain of p53 interfere with
of the ligase. Oncogene 19, 1473–1476. MDM2-dependent protein degradation and ubiquitination. Mol. Cell.
Biol. 20, 9391–9398.Jones, S.N., Roe, A.E., Donehower, L.A., and Bradley, A. (1995).
Rescue of embryonic lethality in Mdm2-deficient mice by absence Ohh, M., Kim, W.Y., Moslehi, J.J., Chen, Y., Chau, V., Read, M.A.,
of P53. Nature 378, 206–208. and Kaelin, W.G., Jr. (2002). An intact NEDD8 pathway is required
for Cullin-dependent ubiquitylation in mammalian cells. EMBO Rep.Kamura, T., Conrad, M.N., Yan, Q., Conaway, R.C., and Conaway,
J.W. (1999). The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase 3, 177–182.
activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev. Osaka, F., Kawasaki, H., Aida, N., Saeki, M., Chiba, T., Kawashima,
13, 2928–2933. S., Tanaka, K., and Kato, S. (1998). A new NEDD8-ligating system
for cullin-4A. Genes Dev. 12, 2263–2268.Karin, M., and Ben-Neriah, Y. (2000). Phosphorylation meets ubiqui-
tination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. Osaka, F., Saeki, M., Katayama, S., Aida, N., Toh-e, A., Kominami,
18, 621–663. K., Toda, T., Suzuki, T., Chiba, T., Tanaka, K., and Kato, S. (2000).
Covalent modifier NEDD8 is essential for SCF ubiquitin-ligase inKawakami, T., Chiba, T., Suzuki, T., Iwai, K., Yamanaka, K., Minato,
N., Suzuki, H., Shimbara, N., Hidaka, Y., Osaka, F., et al. (2001). fission yeast. EMBO J. 19, 3475–3484.
Mdm2 Promotes NEDD8 Conjugation of p53
97
Pozo, J.C., Timpte, C., Tan, S., Callis, J., and Estelle, M. (1998). The
ubiquitin-related protein RUB1 and auxin response in Arabidopsis.
Science 280, 1760–1763.
Querido, E., Blanchette, P., Yan, Q., Kamura, T., Morrison, M., Boivin,
D., Kaelin, W.G., Conaway, R.C., Conaway, J.W., and Branton, P.E.
(2001). Degradation of p53 by adenovirus E4orf6 and E1B55K pro-
teins occurs via a novel mechanism involving a Cullin-containing
complex. Genes Dev. 15, 3104–3117.
Rodriguez, M.S., Desterro, J.M., Lain, S., Midgley, C.A., Lane, D.P.,
and Hay, R.T. (1999). SUMO-1 modification activates the transcrip-
tional response of p53. EMBO J. 18, 6455–6461.
Rodriguez, M.S., Desterro, J.M., Lain, S., Lane, D.P., and Hay, R.T.
(2000). Multiple C-terminal lysine residues target p53 for ubiquitin-
proteasome-mediated degradation. Mol. Cell. Biol. 20, 8458–8476.
Stad, R., Little, N.A., Xirodimas, D.P., Frenk, R., van der Eb, A.J.,
Lane, D.P., Saville, M.K., and Jochemsen, A.G. (2001). Mdmx stabi-
lizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2,
1029–1034.
Stephen, C.W., Helminen, P., and Lane, D.P. (1995). Characterisation
of epitopes on human p53 using phage-displayed peptide libraries:
insights into antibody-peptide interactions. J. Mol. Biol. 248, 58–78.
Tateishi, K., Omata, M., Tanaka, K., and Chiba, T. (2001). The NEDD8
system is essential for cell cycle progression and morphogenetic
pathway in mice. J. Cell Biol. 155, 571–579.
Vousden, K.H. (2002). Activation of the p53 tumor suppressor pro-
tein. Biochim. Biophys. Acta 1602, 47–59.
Weissman, A.M. (2001). Themes and variations on ubiquitylation.
Nat. Rev. Mol. Cell Biol. 2, 169–178.
Woods, Y.L., and Lane, D.P. (2003). Exploiting the p53 pathway for
cancer diagnosis and therapy. Hematol. J. 4, 233–247.
Wu, K., Chen, A., Tan, P., and Pan, Z.Q. (2002). The Nedd8-conju-
gated ROC1-CUL1 core ubiquitin ligase utilizes Nedd8 charged sur-
face residues for efficient polyubiquitin chain assembly catalyzed
by Cdc34. J. Biol. Chem. 277, 516–527.
Xirodimas, D., Saville, M.K., Edling, C., Lane, D.P., and Lain, S.
(2001a). Different effects of p14ARF on the levels of ubiquitinated
p53 and Mdm2 in vivo. Oncogene 20, 4972–4983.
Xirodimas, D.P., Stephen, C.W., and Lane, D.P. (2001b). Cocompart-
mentalization of p53 and Mdm2 is a major determinant for Mdm2-
mediated degradation of p53. Exp. Cell Res. 15, 66–77.
Xirodimas, D.P., Chisholm, J., Desterro, J.M., Lane, D.P., and Hay,
R.T. (2002). P14ARF promotes accumulation of SUMO-1 conjugated
(H)Mdm2. FEBS Lett. 528, 207–211.
Yan, J., Walz, K., Nakamura, H., Carattini-Rivera, S., Zhao, Q., Vogel,
H., Wei, N., Justice, M.J., Bradley, A., and Lupski, J.R. (2003). COP9
signalosome subunit 3 is essential for maintenance of cell prolifera-
tion in the mouse embryonic epiblast. Mol. Cell. Biol. 23, 6798–6808.
